Surgical Oncologist, Dr. Ted James, Joins Advisory Board

Perimeter Medical Imaging Inc., a developer of real time imaging systems for in surgery tumor margin assessment, today announced the addition of Dr. Ted James of University of Vermont to Perimeter’s Clinical Advisory Board.

Dr. James is the Medical Director, Skin & Soft Tissue Surgical Oncology and a Surgical Oncologist, at Fletcher Allen Healthcare and Medical Director, Clinical Simulation and Associate Professor at the University of Vermont College of Medicine.  He is a specialist in Oncoplastic and Minimally Invasive Breast Surgery.  Dr. James is a recognized leader in breast conservation surgery and co-authored one of the key studies on reexcision rates: “Variability in Reexcision Following Breast Conservation Surgery” Laurence E. McCahill, MD; Richard M. Single, PhD; Erin J. Aiello Bowles, MPH; Heather S. Feigelson, PhD, MPH; Ted A. James, MD; Tom Barney, BS; Jessica M. Engel, MSN; Adedayo A. Onitilo, MD, MSCR, JAMA. 2012;307(5):467-475. doi:10.1001/jama.2012.43.

“Today there are no clinically effective tools that have been able to address the large variations in reexcision rates from surgeon to surgeon or hospital to hospital.  As such, in-surgery margin assessment continues to be a challenging clinical problem for surgeons.  Perimeter’s approach is very compelling.  By providing surgeons with real time imaging of the removed tissue, there is the potential to make a very positive impact on the quality of patient care“, said Dr. James.

“Dr. James is a recognized leader in minimally invasive breast surgery.” said Paul Weber, Perimeter’s President and CEO. “It is critical that we engage with thought leaders like Dr. James to assure that our products are as clinically impactful as possible.  Dr. James is passionate about solving the problem of missed tumor margins that is so traumatic for to many patients and I am extremely pleased to have a leader of his calibre joining our team.”

About Perimeter Medical Imaging Inc. 
Perimeter Medical develops, patents, and commercializes advanced surgical imaging tools that allow surgeons, radiologists and pathologists to better assess microscopic tissue structures during the surgical procedure. Perimeter’s OTISTM is the only solution that provides clinicians with an ultra high resolution image of the entire surface of the removed tissue specimen, providing accurate information in real time, enabling better decisions and ultimately reducing the need for follow-on 2nd surgeries.   Perimeter is a privately owned Canadian company.  For more information, visit www.perimetermed.com
 

Media Contact
Paul Weber, President and CEO
Perimeter Medical Imaging Inc.
(647) 504-4260
pweber@perimetermed.com


* CAUTION - OTIS is an investigational device limited by Federal (or United States) law to investigational use. 

kevin chia